Susquehanna International Group
LOGC

Susquehanna International Group’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Susquehanna International Group’s Portfolio LOGC Stock Details LOGC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
2022
Q2 		$8K Buy
2022
Q1 		$10K Sell
2021
Q4 		$58K Sell
2021
Q3 		$211K Buy
2021
Q2 		$126K Buy
2019
Q1 		– Sell
2018
Q4 		$146K Buy